Media
Welcome to BioMarin's Online Press Room.
We’ve brought together a variety of information in one location to better assist you in your efforts to research and develop news articles. Should you require additional information, please call or e-mail us any time.
Corporate Overview
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) develops and commercializes promising therapeutics for patients with severe and/or life-threatening diseases. Since it was founded in 1997, the company has received approval for four breakthrough products—a remarkable accomplishment in the biopharmaceutical industry. By cultivating expertise in research, development and manufacturing, and by streamlining clinical and regulatory development, BioMarin is providing rapid access to treatment and support services to patients around the world suffering from rare genetic diseases. Headquartered in Novato, California, the company operates subsidiary offices in the United Kingdom, Europe, Latin America, the Middle East, and Asia Pacific.
Contact Information:
Bob Purcell
Director, Corporate Communications
corporatecommunications@bmrn.com
415-506-6700
News
